Literature DB >> 16861676

Transcribed var genes associated with placental malaria in Malawian women.

Michael F Duffy1, Aphrodite Caragounis, Rintis Noviyanti, Helen M Kyriacou, Ee Ken Choong, Katja Boysen, Julie Healer, J Alexandra Rowe, Malcolm E Molyneux, Graham V Brown, Stephen J Rogerson.   

Abstract

Determining the diversity of PfEMP1 sequences expressed by Plasmodium falciparum-infected erythrocytes isolated from placentas is important for attempts to develop a pregnancy-specific malaria vaccine. The DBLgamma and var2csa DBL3x domains of PfEMP1 molecules are believed to mediate placental sequestration of infected erythrocytes, so the sequences encoding these domains were amplified from the cDNAs of placental parasites by using degenerate oligonucleotides. The levels of specific var cDNAs were then determined by quantitative reverse transcription-PCR. Homologues of var2csa DBL3x were the predominant sequences amplified from the cDNAs of most placental but not most children's parasites. There was 56% identity between all placental var2csa sequences. Many different DBLgamma domains were amplified from the cDNAs of placental and children's isolates. var2csa transcripts were the most abundant var transcripts of those tested in 11 of 12 placental isolates and 1 of 6 children's isolates. Gravidity did not affect the levels of var2csa transcripts. We concluded that placental malaria is frequently associated with transcription of var2csa but that other var genes are also expressed, and parasites expressing high levels of var2csa are not restricted to pregnant women. The diversity of var2csa sequences may be important for understanding immunity and for the development of vaccines for malaria during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16861676      PMCID: PMC1539630          DOI: 10.1128/IAI.01978-05

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum.

Authors:  Michael F Duffy; Alexander G Maier; Timothy J Byrne; Allison J Marty; Salenna R Elliott; Matthew T O'Neill; Paul D Payne; Stephen J Rogerson; Alan F Cowman; Brendan S Crabb; Graham V Brown
Journal:  Mol Biochem Parasitol       Date:  2006-04-07       Impact factor: 1.759

2.  Maternal antibodies block malaria.

Authors:  M Fried; F Nosten; A Brockman; B J Brabin; P E Duffy
Journal:  Nature       Date:  1998-10-29       Impact factor: 49.962

3.  TreeView: an application to display phylogenetic trees on personal computers.

Authors:  R D Page
Journal:  Comput Appl Biosci       Date:  1996-08

4.  Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns.

Authors:  Patrick E Duffy; Michal Fried
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

5.  Identification of a 67-amino-acid region of the Plasmodium falciparum variant surface antigen that binds chondroitin sulphate A and elicits antibodies reactive with the surface of placental isolates.

Authors:  Benoit Gamain; Joseph D Smith; Marion Avril; Dror I Baruch; Artur Scherf; Jurg Gysin; Louis H Miller
Journal:  Mol Microbiol       Date:  2004-07       Impact factor: 3.501

6.  Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria.

Authors:  Trine Staalsoe; Caroline E Shulman; Judith N Bulmer; Ken Kawuondo; Kevin Marsh; Lars Hviid
Journal:  Lancet       Date:  2004-01-24       Impact factor: 79.321

7.  The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum.

Authors:  Zbynek Bozdech; Manuel Llinás; Brian Lee Pulliam; Edith D Wong; Jingchun Zhu; Joseph L DeRisi
Journal:  PLoS Biol       Date:  2003-08-18       Impact factor: 8.029

8.  Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes and adhesion inhibitory antibodies are associated with placental malaria and have overlapping and distinct targets.

Authors:  James G Beeson; Emily J Mann; Salenna R Elliott; Valentino M Lema; Eyob Tadesse; Malcolm E Molyneux; Graham V Brown; Stephen J Rogerson
Journal:  J Infect Dis       Date:  2004-01-21       Impact factor: 5.226

9.  Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta.

Authors:  M Fried; P E Duffy
Journal:  Science       Date:  1996-06-07       Impact factor: 47.728

10.  Mass spectrometric analysis of Plasmodium falciparum erythrocyte membrane protein-1 variants expressed by placental malaria parasites.

Authors:  Michal Fried; Jason P Wendler; Theonest K Mutabingwa; Patrick E Duffy
Journal:  Proteomics       Date:  2004-04       Impact factor: 3.984

View more
  43 in total

Review 1.  Antigenic variation in Plasmodium falciparum: gene organization and regulation of the var multigene family.

Authors:  Sue A Kyes; Susan M Kraemer; Joseph D Smith
Journal:  Eukaryot Cell       Date:  2007-07-20

2.  Regulation of PfEMP1-VAR2CSA translation by a Plasmodium translation-enhancing factor.

Authors:  Sherwin Chan; Alejandra Frasch; Chandra Sekhar Mandava; Jun-Hong Ch'ng; Maria Del Pilar Quintana; Mattias Vesterlund; Mehdi Ghorbal; Nicolas Joannin; Oscar Franzén; Jose-Juan Lopez-Rubio; Sonia Barbieri; Antonio Lanzavecchia; Suparna Sanyal; Mats Wahlgren
Journal:  Nat Microbiol       Date:  2017-05-08       Impact factor: 17.745

3.  Patterns of protective associations differ for antibodies to P. falciparum-infected erythrocytes and merozoites in immunity against malaria in children.

Authors:  Jo-Anne Chan; Danielle I Stanisic; Michael F Duffy; Leanne J Robinson; Enmoore Lin; James W Kazura; Christopher L King; Peter M Siba; Freya Ji Fowkes; Ivo Mueller; James G Beeson
Journal:  Eur J Immunol       Date:  2017-09-13       Impact factor: 5.532

4.  Transcription of var genes other than var2csa in Plasmodium falciparum parasites infecting Mozambican pregnant women.

Authors:  Eduard Rovira-Vallbona; Carlota Dobaño; Azucena Bardají; Pau Cisteró; Cleofé Romagosa; Elisa Serra-Casas; Llorenç Quintó; Quique Bassat; Betuel Sigaúque; Pedro L Alonso; Jaume Ordi; Clara Menéndez; Alfredo Mayor
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

5.  Advances and challenges in malaria vaccine development.

Authors:  Ruobing Wang; Joseph D Smith; Stefan H I Kappe
Journal:  Expert Rev Mol Med       Date:  2009-12-16       Impact factor: 5.600

6.  Human pregnancy-associated malaria-specific B cells target polymorphic, conformational epitopes in VAR2CSA.

Authors:  Lea Barfod; Nadia L Bernasconi; Madeleine Dahlbäck; David Jarrossay; Pernille Haste Andersen; Ali Salanti; Michael F Ofori; Louise Turner; Mafalda Resende; Morten A Nielsen; Thor G Theander; Federica Sallusto; Antonio Lanzavecchia; Lars Hviid
Journal:  Mol Microbiol       Date:  2006-12-14       Impact factor: 3.501

7.  Optimizing expression of the pregnancy malaria vaccine candidate, VAR2CSA in Pichia pastoris.

Authors:  Marion Avril; Marianne J Hathaway; Megan M Cartwright; Severin O Gose; David L Narum; Joseph D Smith
Journal:  Malar J       Date:  2009-06-29       Impact factor: 2.979

8.  Towards the rational design of a candidate vaccine against pregnancy associated malaria: conserved sequences of the DBL6epsilon domain of VAR2CSA.

Authors:  Cyril Badaut; Gwladys Bertin; Tatiana Rustico; Nadine Fievet; Achille Massougbodji; Alioune Gaye; Philippe Deloron
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

9.  A molecular switch in the efficiency of translation reinitiation controls expression of var2csa, a gene implicated in pregnancy-associated malaria.

Authors:  Cristina Bancells; Kirk W Deitsch
Journal:  Mol Microbiol       Date:  2013-09-16       Impact factor: 3.501

10.  An upstream open reading frame controls translation of var2csa, a gene implicated in placental malaria.

Authors:  Borko Amulic; Ali Salanti; Thomas Lavstsen; Morten A Nielsen; Kirk W Deitsch
Journal:  PLoS Pathog       Date:  2009-01-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.